Intralesional interferon alpha-2b therapy for Buschke-Loewenstein tumour.
Tsambaos D, Monastirli A, Kapranos N, Georgiou S, Pasmatzi E, Berger H
DOI: 10.2340/0001555574457459
Abstract
A patient with a Buschke-Loewenstein tumour associated with human papillomavirus type 6/11 is reported. He was intralesionally treated with human recombinant alpha-2b interferon (9 x 10(6) IU/day) three times weekly. The tumour completely disappeared within 5 months of continuous treatment which was well tolerated. Sixteen months after completion of therapy the patient remains well and free of disease.
Significance
Supplementary content
Comments